SWHR Submits Comments on FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women

REGULATORY POLICY

Published 9/25/25

The Society for Women’s Health Research (SWHR) submitted comments in response to the U.S. Food and Drug Administration’s Expert Panel on Menopause and Hormone Replacement Therapy for Women. In the comment, SWHR emphasizes the importance of ensuring women have access to safe and effective treatments for menopause symptoms and highlights concerns that outdated warnings create barriers to care.

View the Letter